SYMPHOGEN
Summary
Symphogen is a privately-owned biotech company focused on oncology and immuno-oncology.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
Senior Management
Martin Olin
CEO
Bernhard Ehmer
Chairman